The UK government recently unveiled its 10-year Life Sciences Sector Plan, putting forward a comprehensive strategy for transforming the UK into a global leader in life sciences by 2035. This LawFlash outlines key areas of...more
While the US Food and Drug Administration has been experiencing recent reorganization and cuts in personnel, the United Kingdom has its own upcoming policy changes making it easier and faster to initiate and maintain UK...more
With telehealth surging around the globe due to the COVID-19 pandemic, the UK National Health Services has released guidance that provides a set of good practice principles for third-party partners to follow....more
2/5/2021
/ Coronavirus/COVID-19 ,
Data Protection ,
Electronic Protected Health Information (ePHI) ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Infectious Diseases ,
Life Sciences ,
Patient Access ,
Personal Data ,
Regulatory Agenda ,
Telehealth ,
Telemedicine ,
UK
From disrupting the supply of medical devices to affecting how they are regulated and sold in the United Kingdom (UK), Brexit could carry significant implications for UK healthcare and trade....more
Welcome to the third issue of our European Life Sciences Review that covers some of the most critical developments in the pharmaceutical and medical technology sectors in the last month and is produced by our life sciences...more
7/16/2016
/ Anti-Competitive ,
Anti-Corruption ,
Clinical Trials ,
Data Protection ,
EU ,
EU-US Privacy Shield ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Medical Devices ,
Mobile Health Apps ,
Off-Label Promotion ,
Pharmaceutical Industry ,
TTIP ,
UK ,
UK Brexit ,
UK Competition and Markets Authority (CMA)
Welcome to the first issue of our EU Life Sciences Review . It is produced by our life sciences lawyers in London, Brussels, Frankfurt, Moscow, and Paris and covers some of the most critical developments in the pharmaceutical...more
2/2/2016
/ Biotechnology ,
EU ,
European Commission ,
European Court of Justice (ECJ) ,
European Food Safety Authority (EFSA) ,
General Data Protection Regulation (GDPR) ,
Hazardous Waste ,
Life Sciences ,
Orphan Drugs ,
Personalized Medicine ,
The Patent Box ,
UK ,
Unitary Patent ,
US-EU Safe Harbor Framework